Choroidal excavation is a recently described entity.\[[@ref1]\] Focal choroidal excavation (FCE) with PCV has been reported before.\[[@ref2]\] Optical coherence tomography angiography (OCT-A) features of PCV have also been described.\[[@ref3]\] Hereby, we describe clinical and imaging features of juxtapapillary choroidal excavation (JCE) with PCV. To the best of our knowledge, JCE and PCV have not been reported together before.

Case Report {#sec1-2}
===========

A 27-year-old-lady presented with decreased vision in right eye, of 3-year duration. Best corrected visual acuity was 20/60. Left eye was normal. Fundus examination revealed juxtapapillary retinal pigment epithelium-choroidal atrophy \[[Fig. 1](#F1){ref-type="fig"}\] with overlying subretinal fluid \[[Fig. 1](#F1){ref-type="fig"}\], and cystoid macular edema. Clinical findings were confirmed with swept-source OCT \[[Fig. 2](#F2){ref-type="fig"}\]. A hyperreflective polypoidal lesion was seen within area of choroidal excavation \[[Fig. 2](#F2){ref-type="fig"}\]. Fundus fluorescein angiography showed diffuse hyperfluorescence corresponding to choroidal excavation \[[Fig. 3](#F3){ref-type="fig"}\] and progressive focal hyperfluorescence corresponding to polypoidal lesion \[[Fig. 3](#F3){ref-type="fig"}\]. OCT-A showed lack of choriocapillaris within the area of choroidal excavation \[[Fig. 4](#F4){ref-type="fig"}\]. A hypoflow structure surrounded by a hyperflow area was also seen in the choriocapillaris at the same level \[[Fig. 4](#F4){ref-type="fig"}\]. Although indocyanine green angiography is investigation of choice for PCV, requisite information could be gathered from OCT-A in our case.

![Color fundus photo shows an area of retinal pigment epithelium -choroid atrophy (white arrows) with overlying subretinal fluid (white arrowheads) in the juxtapapillary region](IJO-67-401-g001){#F1}

![Swept-source optical coherence tomography shows retinal pigment epithelium atrophy overlying an area of choroidal excavation with subretinal fluid. CME is noted. A hyperreflective polypoidal lesion is seen within the area of choroidal excavation (white arrow)](IJO-67-401-g002){#F2}

![Fundus fluorescein angiography shows an area of diffuse hyperfluorescence corresponding to the choroidal excavation (white arrowheads) and progressive focal hyperfluorescence corresponding to the polypoidal lesion (white arrow)](IJO-67-401-g003){#F3}

![Optical coherence tomography angiography (OCT-A) shows an area devoid of choriocapillaries in the region corresponding to diffuse choroidal excavation (white stars). A hyperflow network is seen in OCT-A at the level of the polypoidal lesion in swept-source optical coherence tomography (broad arrow). A hypoflow structure surrounded by a hyperflow area is also seen in the choriocapillaris at the same level (white arrowhead)](IJO-67-401-g004){#F4}

Discussion {#sec1-3}
==========

FCE has an association with PCV.\[[@ref2]\] Individually, OCT features of FCE and PCV have been well documented.\[[@ref4]\] OCT-A features of PCV have been described.\[[@ref5]\] In our case, JCE appears as a hypoflow area. This can be attributed to choriocapillaris attenuation in this region. It is possible that a prior episode of subretinal bleeding from polypoidal lesion is responsible for choroidal atrophic changes, but a cause--effect relationship is hard to establish in the absence of a longitudinal study. Larger studies with longer follow-up are required to understand the two entities better.
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